Cadonilimab Combined with Chemotherapy with or without Bevacizumab as First-Line Treatment in Recurrent or Metastatic Cervical Cancer (COMPASSION-13): A Phase 2 Study - Concepedia

Concepedia

Publication | Open Access

Cadonilimab Combined with Chemotherapy with or without Bevacizumab as First-Line Treatment in Recurrent or Metastatic Cervical Cancer (COMPASSION-13): A Phase 2 Study

DOI Full Paper Access

46

Citations

18

References

2024

Year

Hanmei Lou, Hongbing Cai, Xin Huang, Guiling Li, Li Wang, Fei Liu, Wenjing Qin, Ting Liu, Wei Liu, Zhongmin Maxwell Wang,

Clinical Cancer Research

Abstract

Cadonilimab combined with standard therapy was acceptable, with encouraging antitumor activity in patients with R/M CC.

References

	Year	Citations

Page 1